MARKET

SUPN

SUPN

Supernus Inc
NASDAQ
29.72
+0.52
+1.78%
After Hours: 29.51 -0.21 -0.71% 19:30 11/13 EST
OPEN
29.41
PREV CLOSE
29.20
HIGH
29.92
LOW
28.81
VOLUME
2.07M
TURNOVER
--
52 WEEK HIGH
31.62
52 WEEK LOW
16.52
MARKET CAP
3.51B
P/E (TTM)
8.32
1D
5D
1M
3M
1Y
5Y
1D
Bank of America Names 2 ‘Strong Buy’ Stocks With 60%+ Upside
TipRanks · 2d ago
Is Supernus (SUPN) Undervalued After Joining The Nasdaq Composite?
Simply Wall St · 4d ago
This Supernus Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Benzinga · 4d ago
Supernus Pharmaceuticals Initiated at Buy by B of A Securities
Dow Jones · 5d ago
Supernus Pharmaceuticals Price Target Announced at $47.00/Share by B of A Securities
Dow Jones · 5d ago
B of A Securities Initiates Coverage On Supernus with Buy Rating, Announces Price Target of $47
Benzinga · 5d ago
Supernus initiated with a Buy at BofA
TipRanks · 5d ago
Weekly Report: what happened at SUPN last week (1102-1106)?
Weekly Report · 5d ago
More
About SUPN
Supernus, Inc., formerly Indivior Pharmaceuticals, Inc., is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The Company's commercial platform offers various product portfolios consisting of opioid use disorder, psychiatry, and neurology, and includes five core growth drivers, including SUBLOCADE, Qelbree, GOCOVRI, ONAPGO, and ZURZUVAE. Its portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.

Webull offers Supernus, Inc. stock information, including NASDAQ: SUPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SUPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SUPN stock methods without spending real money on the virtual paper trading platform.